ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

ACR Convergence 2022

November 10-14, 2022. Philadelphia, PA.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 0567
    Gain-of-Function Mutations in Lyn Kinase Cause a Novel Autoinflammatory Disease with Small Vessel Vasculitis and Liver Fibrosis
  • Abstract Number: 1784
    Gait Alterations Associated with Worsening Physical Function over 2 Years: A Machine-learning Approach in the Multicenter Osteoarthritis (MOST) Study
  • Abstract Number: 1920
    Gait and Physical Activity Predictors of Knee Replacement: A Machine Learning Analysis in the Multicenter Osteoarthritis Study
  • Abstract Number: 2159
    Gastroesophageal Reflux Disease in an Australian Scleroderma Cohort – Associations and Effect of Treatment
  • Abstract Number: 1445
    Gastrointestinal Manifestations in Systemic Lupus Erythematosus Are Associated with High Disease Activity and Mortality: A Nationwide Cohort Study from India
  • Abstract Number: 0882
    Gender Differences in Rheumatology Authorship: A Bibliometric Analysis of High Impact Rheumatology Journals from 2019-2021
  • Abstract Number: 0111
    Gender Equity in the Asia Pacific: Comparison of Indian and Philippines Rheumatology Conferences
  • Abstract Number: 0104
    Gender Representation of the Editors and Editorial Boards of the Top 45 Rheumatology-Focused Journals
  • Abstract Number: 1219
    Gender-Related Clinical Profile of Fibromyalgia Patients
  • Abstract Number: 1539
    Gene Expression Meta-Analysis Reveals Aging and Cellular Senescence Signatures in Scleroderma-associated Interstitial Lung Disease
  • Abstract Number: 0361
    Gene Expression Pathways Modulated by Anifrolumab in Systemic Lupus Erythematosus
  • Abstract Number: 0486
    Gene Expression Profile of Temporal Artery Tissue and Whole Blood in Giant Cell Arteritis
  • Abstract Number: 2224
    Genes Causative of Primary Immunodeficiency Are Risk Factors for and Over-expressed in Systemic Lupus Erythematosus
  • Abstract Number: 2250
    Genetic and Environmental Risk Factors in Rheumatoid Arthritis-Associated Interstitial Lung Disease
  • Abstract Number: 1038
    Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Ankylosing Spondylitis
  • Abstract Number: 1146
    Genetic Interactions Between T-Cell Receptor Polymorphisms and HLA Amino Acids Contribute to the Risk of Rheumatoid Arthritis
  • Abstract Number: 1633
    Genetic Risk, Adherence to a Healthy Lifestyle, and Incident Gout in US Women and Men
  • Abstract Number: 1940
    Genetic Variants and Cytokine Signatures in Patients with Syndrome of Undifferentiated Recurrent Fevers
  • Abstract Number: 1892
    Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomised Double-blind Placebo Controlled Trial
  • Abstract Number: 1134
    Genome-wide Association Study Identifies Novel Loci for Leukopenia Among TPMT and NUDT15 Normal Metabolizers Taking Azathioprine
  • Abstract Number: 1621
    Genome-wide Association Study in African American Systemic Sclerosis Patients Identifies a Novel Target – Transforming Growth Factor-β3 (TGFβ3)
  • Abstract Number: 1125
    Genomics of JAK-STAT Signaling in Venous Thromboembolism
  • Abstract Number: 0072
    Geographical Patterns of Healthcare Utilization Among RA and OA Patients
  • Abstract Number: 0489
    Giant Cell Arteritis Phenotypes and Diagnosis of Aortitis Among 1852 Patients Before and After 2016 Across 10 French Referral Centers
  • Abstract Number: 0496
    Giant Cell Arteritis Relapse Risk – Could the Extent of Vessel Involvement on Temporal and Axillary Arteries Ultrasound Be a Prognostic Marker?
  • Abstract Number: 0483
    Giant Cell Arteritis: Physical Examination of the Superficial Temporal Arteries Can Predict Temporal Artery Biopsy Result
  • Abstract Number: 1078
    Glucocorticoid Use and Related Adverse Events in ADVOCATE Trial of Avacopan in ANCA-Associated Vasculitis
  • Abstract Number: 0481
    Glucocorticoid-related Adverse Events in Giant Cell Arteritis: Application of the Glucocorticoid Toxicity Index in a Monocentric Cohort of 140 Patients
  • Abstract Number: 1304
    Glucocorticoids Affect Bone Mass and Strength by Inhibiting Osteoprogenitor Cell Maturation
  • Abstract Number: 0879
    Golimumab for Treatment of Polyarticular Juvenile Idiopathic Arthritis – Safety and Effectiveness Updates from a Comparative Study
  • Abstract Number: 1789
    Gout in Heart Failure Patients with Left Ventricular Assist Device Therapy in a Tertiary Academic Hospital
  • Abstract Number: 1733
    Granzyme K Elicits a New Pathway for Complement Activation in RA Synovium
  • Abstract Number: 1253
    Gray Intensity Ratio Indices as a Method of Discrimination Between Changes Induced by Sport and by Spondyloarthritis in Load-bearing Entheses
  • Abstract Number: 2092
    Greater Social Vulnerability Associates with Greater Glucocorticoid Use in Patients with SLE
  • Abstract Number: 0150
    Growth and Differentiation Factor 15, an Emerging Biomarker of Mitochondrial Dysfunction- Associated Myopathies: Implications for Juvenile Dermatomyositis
  • Abstract Number: 2110
    Guselkumab Efficacy in Psoriatic Arthritis Assessed by Multi-domain Composite Indices: Data from the Phase 3b COSMOS Trial in a TNFi-IR Population
  • Abstract Number: 2127
    Guselkumab Provides Continued Improvement in Key Domains of Psoriatic Arthritis Through 2 Years
  • Abstract Number: 1850
    Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
  • Abstract Number: 0509
    Guselkumab Provides Sustained Improvements in Work Productivity and Daily Activity in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
  • Abstract Number: 0507
    Gut Microbe Metabolite Short-Chain Fatty Acids May Associate with Development of Respiratory Involvement in Patients with Relapsing Polychondritis
  • Abstract Number: 2181
    Gut Microbe-derived Short-Chain Fatty Acids Regulate Arthritis and Myositis During Chikungunya Virus Infection
  • Abstract Number: 1148
    GWAS Identified New Genes in Synovial Fibroblasts Linked to Early Remission in RA
Jump to:  View All • a b c d e f [g] h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology